Learn how early collaboration with an integrated solutions provider can help to mitigate supply challenges.

Which therapeutic areas are ripe for highly decentralized trials? Which areas will be least resistant to this kind of change?

Summary: Catalent’s clinical supply packaging facility in Shiga, Japan is strategically located between Tokyo and Osaka. One of largest in Japan, the 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global...

The current understanding among sponsors of the workflow from cell collection, to manufacturing, and ultimately to the clinical site for patient administration.

Offering Fact Sheet-OneBio® Integrated Suite

Offering Fact Sheet - OptiForm® Total Supply

Explore how an experienced partner can provide invaluable guidance and offer creative solutions when selecting a primary packaging format.

The benefits of direct-to-patient supply to mitigate risk in decentralized studies.

The reasons behind implementing a multi-segment Phase 2 study and implications on kit design.

Proactive Clinical Supply Planning-Early to Late Phase